Early Detection and Diagnosis

You have full text access to this OnlineOpen article

Novel markers for poor prognosis in head and neck cancer

  1. David Chin1,4,5,†,*,
  2. Glen M. Boyle1,
  3. Rebecca M. Williams3,
  4. Kaltin Ferguson1,
  5. Nirmala Pandeya2,
  6. Julie Pedley1,
  7. Catherine M. Campbell3,
  8. David R. Theile4,
  9. Peter G. Parsons1,
  10. William B. Coman5

Article first published online: 21 OCT 2004

DOI: 10.1002/ijc.20608

Issue

International Journal of Cancer

International Journal of Cancer

Volume 113, Issue 5, pages 789–797, 20 February 2005

Additional Information

How to Cite

Chin, D., Boyle, G. M., Williams, R. M., Ferguson, K., Pandeya, N., Pedley, J., Campbell, C. M., Theile, D. R., Parsons, P. G. and Coman, W. B. (2005), Novel markers for poor prognosis in head and neck cancer. Int. J. Cancer, 113: 789–797. doi: 10.1002/ijc.20608

Author Information

  1. 1

    Melanoma Genomics Group, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia

  2. 2

    Cancer and Population Studies Group, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia

  3. 3

    Pathology Unit, University of Queensland, Princess Alexandra Hospital, Woollongabba, Brisbane, Queensland, Australia

  4. 4

    Plastic Surgery Unit, University of Queensland, Princess Alexandra Hospital, Woollongabba, Brisbane, Queensland, Australia

  5. 5

    Head and Neck Unit, University of Queensland, Princess Alexandra Hospital, Woollongabba, Brisbane, Queensland, Australia

  1. †

    Fax: +61-7-3845-3508

*Head and Neck Unit, University of Queensland, Princess Alexandra Hospital, Woollongabba, Brisbane, 4102, Queensland, Australia

Publication History

  1. Issue published online: 8 DEC 2004
  2. Article first published online: 21 OCT 2004
  3. Manuscript Accepted: 21 JUL 2004
  4. Manuscript Received: 19 MAR 2004

Funded by

  • Garnett-Passe and Rodney Williams Memorial Foundation Project Grant
  • University of Queensland Graduate Medical School Scholarship
  • Queensland Cancer Fund Clinical Fellowship

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (505K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Valentina Guarneri, Maria Vittoria Dieci, PierFranco Conte, Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer, Expert Opinion on Pharmacotherapy, 2012, 13, 3, 395

    CrossRef

  2. 2
    Alexandra V. Lucs, Benjamin Saltman, Christine H. Chung, Bettie M. Steinberg, David L. Schwartz, Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment, Head & Neck, 2012, 34, 6
    Direct Link:
  3. 3
    Shirley S. Arielly, Matty Ariel, Rivka Yehuda, Michaela Scigelova, Galit Yehezkel, Isam Khalaila, Quantitative analysis of caveolin-rich lipid raft proteins from primary and metastatic colorectal cancer clones, Journal of Proteomics, 2012, 75, 9, 2629

    CrossRef

  4. 4
    Hai-Yun Wang, Yang-Yang Li, Qiong Shao, Jing-Hui Hou, Fang Wang, Man-Bo Cai, Yi-Xin Zeng, Jian-Yong Shao, Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis, Journal of Translational Medicine, 2012, 10, 1, 27

    CrossRef

  5. 5
    A Kolk, N Jubitz, K Mengele, K Mantwill, O Bissinger, M Schmitt, M Kremer, P S Holm, Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients, British Journal of Cancer, 2011, 105, 12, 1864

    CrossRef

  6. 6
    Mario Pérez-Sayáns, José Manuel Suárez-Peñaranda, Pilar Gayoso-Diz, Francisco Barros-Angueira, José Manuel Gándara-Rey, Abel García-García, p16INK4a/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?, Cancer Letters, 2011, 306, 2, 134

    CrossRef

  7. 7
    Brent B. Ward, Thomas Dunham, Istvan J. Majoros, James R. Baker, Targeted Dendrimer Chemotherapy in an Animal Model for Head and Neck Squamous Cell Carcinoma, Journal of Oral and Maxillofacial Surgery, 2011, 69, 9, 2452

    CrossRef

  8. 8
    Javier Cortes, Cristina Saura, Nanoparticle albumin-bound (nabâ„¢)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer, European Journal of Cancer Supplements, 2010, 8, 1, 1

    CrossRef

  9. 9
    Marija Pastorcic-Grgic, Bozena Sarcevic, Danijel Dosen, Antonio Juretic, Giulio C. Spagnoli, Marko Grgic, Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer, Head & Neck, 2010, 32, 9
    Direct Link:
  10. 10
    D. Capper, M. Mittelbronn, B. Goeppert, R. Meyermann, J. Schittenhelm, Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival, Neuropathology and Applied Neurobiology, 2010, 36, 3
    Direct Link:
  11. 11
    Chi T. Viet, Brian L. Schmidt, Understanding oral cancer in the genome era, Head & Neck, 2010, 32, 9
    Direct Link:
  12. 12
    Shanna A. Arnold, Rolf A. Brekken, SPARC: a matricellular regulator of tumorigenesis, Journal of Cell Communication and Signaling, 2009, 3, 3-4, 255

    CrossRef

  13. 13
    N Said, H F Frierson, D Chernauskas, M Conaway, K Motamed, D Theodorescu, The role of SPARC in the TRAMP model of prostate carcinogenesis and progression, Oncogene, 2009, 28, 39, 3487

    CrossRef

  14. 14
    Clancy J. Clark, E. Helene Sage, A prototypic matricellular protein in the tumor microenvironment—Where there's SPARC, there's fire, Journal of Cellular Biochemistry, 2008, 104, 3
    Direct Link:
  15. 15
    Neil P. Desai, Vuong Trieu, Larn Yuan Hwang, Rujin Wu, Patrick Soon-Shiong, William J. Gradishar, Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status, Anti-Cancer Drugs, 2008, 19, 9, 899

    CrossRef

  16. 16
    Jan Bernd Weise, Pierre Rudolph, Axel Heiser, Marie-Luise Kruse, Jürgen Hedderich, Christian Cordes, Markus Hoffmann, Ommo Brant, Petra Ambrosch, Katalin Csiszar, Tibor Görögh, LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer, European Journal of Cancer, 2008, 44, 9, 1323

    CrossRef

  17. 17
    Matti S. Aapro, Gunter Von Minckwitz, Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer, European Journal of Cancer Supplements, 2008, 6, 10, 3

    CrossRef

  18. 18
    Xiaolian Gu, Philip J. Coates, Linda Boldrup, Karin Nylander, p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck, Cancer Letters, 2008, 263, 1, 26

    CrossRef

  19. 19
    Christine Bayer, Daniela Schilling, Joerg Hoetzel, Hannes Peter Egermann, Daniel Zips, Ala Yaromina, Anneke Geurts-Moespot, Lisa Deborah Sprague, Fred Sweep, Michael Baumann, Michael Molls, Markus Adam, PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck, Radiotherapy and Oncology, 2008, 86, 3, 361

    CrossRef

  20. 20
    Bernd R. Binder, Judit Mihaly, The plasminogen activator inhibitor “paradox” in cancer, Immunology Letters, 2008, 118, 2, 116

    CrossRef

  21. 21
    Osvaldo L. Podhajcer, Lorena Benedetti, Maria Romina Girotti, Federico Prada, Edgardo Salvatierra, Andrea S. Llera, The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host, Cancer and Metastasis Reviews, 2008, 27, 3, 523

    CrossRef

  22. 22
    Osvaldo L. Podhajcer, Lorena Gabriela Benedetti, Maria Romina Girotti, Federico Prada, Edgardo Salvatierra, Andrea S. Llera, The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host, Cancer and Metastasis Reviews, 2008, 27, 4, 691

    CrossRef

  23. 23
    Sunny Y. Wong, Denise Crowley, Roderick T. Bronson, Richard O. Hynes, Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer, Clinical & Experimental Metastasis, 2007, 25, 2, 109

    CrossRef

  24. 24
    Bruno Damascelli, Gianluigi Patelli, Vladimira Tichá, Giuseppe Di Tolla, Laura F. Frigerio, Francesco Garbagnati, Rodolfo Lanocita, Alfonso Marchianò, Carlo Spreafico, Franco Mattavelli, Andrea Bruno, Franco Zunino, Feasibility and Efficacy of Percutaneous Transcatheter Intraarterial Chemotherapy with Paclitaxel in Albumin Nanoparticles for Advanced Squamous-Cell Carcinoma of the Oral Cavity, Oropharynx, and Hypopharynx, Journal of Vascular and Interventional Radiology, 2007, 18, 11, 1395

    CrossRef

  25. 25
    Thomas E Stinchcombe, Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL®-free formulation of paclitaxel, Nanomedicine, 2007, 2, 4, 415

    CrossRef

  26. 26
    Luciënne Speleman, Jeroen D. F. Kerrebijn, Maxime P. Look, Cees A. Meeuwis, John A. Foekens, Els M. J. J. Berns, Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma, Head & Neck, 2007, 29, 4
    Direct Link:
  27. 27
    Lisa D. Sprague, Karin Mengele, Daniela Schilling, Anneke Geurts-Moespot, Fred C.G.J. Sweep, Peter Stadler, Manfred Schmitt, Michael Molls, Effect of Reoxygenation on the Hypoxia-Induced Up-Regulation of Serine Protease Inhibitor PAI-1 in Head and Neck Cancer Cells, Oncology, 2006, 71, 3-4, 282

    CrossRef

  28. 28
    Tanya R. Newton, Peter G. Parsons, Douglas J. Lincoln, Margaret C. Cummings, David K. Wyld, Penelope M. Webb, Adele C. Green, Glen M. Boyle, Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer, International Journal of Cancer, 2006, 119, 4
    Direct Link:
  29. 29
    David Chin, Glen M Boyle, Sandro Porceddu, David R Theile, Peter G Parsons, William B Coman, Head and neck cancer: past, present and future, Expert Review of Anticancer Therapy, 2006, 6, 7, 1111

    CrossRef

  30. 30
    Eloy Roman, Luis E Raez, Edgardo S Santos, Induction chemotherapy in the management of squamous cell carcinoma of the head and neck, Expert Review of Anticancer Therapy, 2006, 6, 9, 1205

    CrossRef

  31. 31
    Cs-F Hooi, C Blancher, W Qiu, I M Revet, L H Williams, M L Ciavarella, R L Anderson, E W Thompson, A Connor, W A Phillips, I G Campbell, ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix, Oncogene, 2006, 25, 28, 3924

    CrossRef

  32. 32
    David Chin, Glen M. Boyle, David R. Theile, Peter G. Parsons, William B. Coman, The human genome and gene expression profiling, Journal of Plastic, Reconstructive & Aesthetic Surgery, 2006, 59, 9, 902

    CrossRef

  33. 33
    David Chin, Glen M. Boyle, Rebecca M. Williams, Kaltin Ferguson, Nirmala Pandeya, Julie Pedley, Catherine M. Campbell, David R. Theile, Peter G. Parsons, William B. Coman, Alpha B-Crystallin, a New Independent Marker for Poor Prognosis in Head and Neck Cancer, The Laryngoscope, 2005, 115, 7
    Direct Link:
  34. 34
    Peter Choi, Chu Chen, Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma, Cancer, 2005, 104, 6
    Direct Link:
View Full Article (HTML) Get PDF (505K)